J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Price:
156
SAR
4.7%
Market Closed
Market Cap:
﷼10.9B
Relative Value
The Relative Value of one Jamjoom Pharmaceuticals Factory Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 156 SAR, Jamjoom Pharmaceuticals Factory Company SJSC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Jamjoom Pharmaceuticals Factory Company SJSC Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Jamjoom Pharmaceuticals Factory Company SJSC Competitors
Jamjoom Pharmaceuticals Factory Company SJSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SA |
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
10.9B SAR | 7.3 | 23.5 | 20.4 | 22.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
934.5B USD | 14.3 | 45.3 | 30.5 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.6B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
257.3B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.3 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.6B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.3B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
